VR Adviser’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-615,506
| Closed | -$3.87M | – | 40 |
|
|
2025
Q1 | $3.87M | Sell |
615,506
-650,951
| -51% | -$4.09M | 0.33% | 28 |
|
|
2024
Q4 | $5.22M | Sell |
1,266,457
-2,156,199
| -63% | -$8.88M | 0.36% | 30 |
|
|
2024
Q3 | $11.4M | Buy |
3,422,656
+19
| +0% | +$63 | 0.6% | 28 |
|
|
2024
Q2 | $10.2M | Sell |
3,422,637
-38
| -0% | -$113 | 0.65% | 30 |
|
|
2024
Q1 | $11.8M | Buy |
3,422,675
+278
| +0% | +$959 | 0.56% | 33 |
|
|
2023
Q4 | $4.59M | Hold |
3,422,397
| – | – | 0.31% | 33 |
|
|
2023
Q3 | $7.46M | Hold |
3,422,397
| – | – | 0.79% | 28 |
|
|
2023
Q2 | $8.18M | Buy |
3,422,397
+372,375
| +12% | +$890K | 1.31% | 18 |
|
|
2023
Q1 | $5.64M | Hold |
3,050,022
| – | – | 1.1% | 20 |
|
|
2022
Q4 | $5.89M | Hold |
3,050,022
| – | – | 0.99% | 22 |
|
|
2022
Q3 | $4.7M | Hold |
3,050,022
| – | – | 0.72% | 25 |
|
|
2022
Q2 | $8.57M | Buy |
+3,050,022
| New | +$8.57M | 1.69% | 17 |
|